Abstract
Human pluripotent stem cells (hPSCs) are known to harbor chromosomal aberrations, affecting their tumorigenic potential. We established a strategy to identify cancer-related point mutations in hPSCs, detecting recurrent mutations in over 20 genes, alongside those previously detected in p53. Importantly, naive hPSCs harbor, on average, four times more mutations than their primed counterparts, which appear primarily in pathways inhibited during naive conversion. Such cancer-related mutations should be taken into consideration in future applications, especially in clinical contexts.
| Original language | English |
|---|---|
| Pages (from-to) | 456-461 |
| Number of pages | 6 |
| Journal | Cell Stem Cell |
| Volume | 25 |
| Issue number | 4 |
| DOIs | |
| State | Published - 3 Oct 2019 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Inc.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Cancer-Related Mutations Identified in Primed and Naive Human Pluripotent Stem Cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver